The trading activity within ITRON, INC. (NASDAQ:ITRI) suggests ongoing internal movements amid recent operational updates. On May 20, 2026, Laurie Ann Pulatie-Hahn, who serves as Senior Vice President of Human Resources at the firm, executed a sale of company common stock.
Specifically, Ms. Pulatie-Hahn sold 181 shares of Itron's common stock for a total value of $14,407. The reported selling price was $79.5976 per share. This transaction was noted as being executed to satisfy tax withholding obligations linked to the vesting of restricted stock unit awards.
The timing of this sale is notable given that the company's stock was trading near its 52-week low, which stood at $77.77, according to data provided by InvestingPro. Furthermore, the same analysis indicated that Itron might be undervalued based on its Fair Value assessment.
Beyond the insider transaction, Itron Inc. recently disclosed its financial results for the first quarter of 2026. These reported figures demonstrated performance that exceeded what had been anticipated by market analysts. The company recorded earnings per share (EPS) of $1.49, which was higher than the projected estimate of $1.23. Similarly, revenue also surpassed forecasts, reaching $587 million when analysts had predicted $572.09 million.
Despite these positive financial results regarding both earnings and top-line revenue, Itron's stock experienced a notable decline during pre-market trading hours. This movement suggests that some investor concerns persist regarding the company’s overall performance trajectory and its future outlook.
This mixed market sentiment was compounded by an adjustment made by Roth/MKM. The firm adjusted its price target for Itron, reducing it from $150 to $136. However, Roth/MKM maintained its rating of Buy despite this reduction. This downward revision in the price target was attributed specifically to a more subdued near-term revenue growth trajectory. Such slower anticipated growth is linked to complex projects and prevailing regulatory dynamics within the industry.
Following the sale, Ms. Pulatie-Hahn's direct holdings of Itron common stock totaled 32,469 shares. These developments underscore a period of varied sentiment surrounding Itron’s recent market performance and its anticipated future prospects, given both the positive financial metrics and the simultaneous concerns raised by analysts.